LifeStance Health Group (LFST)
(Delayed Data from NSDQ)
$5.55 USD
+0.04 (0.73%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $5.54 -0.01 (-0.18%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth D Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
LFST 5.55 +0.04(0.73%)
Will LFST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LFST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LFST
Encompass Health (EHC) Q2 Earnings Beat Estimates
LifeStance Health Group (LFST) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
LFST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Does LifeStance Health (LFST) Have the Potential to Rally 54.84% as Wall Street Analysts Expect?
All You Need to Know About LifeStance Health (LFST) Rating Upgrade to Strong Buy
Wall Street Analysts See a 57.38% Upside in LifeStance Health (LFST): Can the Stock Really Move This High?
Other News for LFST
7 Low-Cost Stocks With Unexpected Growth Potential
LifeStance Survey Finds US Adults Prioritize Access to Therapy Over Free Taylor Swift Tickets and Vacations
LIfeist Shrinks Net Loss: 49% YoY Drop In Q2 Net Revenue, Plans Move Away From Its Legacy Cannabis Business
Lifeist Reports Second Quarter 2024 Financial Results
Lifeist Wellness Pivots Amidst Financial Downturn